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Abstract
Background/Aim Gene variants encoding for proteins involved in homeostatic processes 
within tendons may influence its material and mechanical properties in humans.  The purpose 
of this study was to examine the association between three polymorphisms of the MMP3 
gene, (rs679620, rs591058 and rs650108) and patellar tendon dimensional and mechanical 
properties in vivo. 
Methods 160 healthy, recreationally-active, Caucasian, men and women, aged 18-39 were 
recruited. Women were not recruited if they were pregnant or using any form of hormone-
based contraception. MMP3 genotype determined using real-time PCR was used to select 84 
participants showing greatest genetic differences to complete phenotype measurements. 
Patellar tendon dimensions (volume) and functional (elastic modulus) properties were 
assessed in vivo using geometric modelling, isokinetic dynamometry, electromyography and 
ultrasonography.
Results: No significant associations were evident between the completely linked MMP3 
rs591058 and rs679620 gene variants, and closely linked rs650108 gene variant, and either 
patellar tendon volume (rs679620, P = 0.845; rs650108, P = 0.984) or elastic modulus 
(rs679620, P = 0.226; rs650108, P = 0.088). Similarly, there were no associations with the Z-
score that combined those dimension and functional properties into a composite value 
(rs679620, P = 0.654; rs650108, P = 0.390). Similarly, no association was evident when 
comparing individuals with/without the rarer alleles (P > 0.01 in all cases).
Conclusions: Patellar tendon properties do not seem to be influenced by the MMP3 gene 
variants measured. Although these MMP3 gene variants have previously been associated with 
the risk of tendon pathology, that association is unlikely to be mediated via underlying tendon 
dimensional and functional properties.
Introduction
Knowledge of the mechanical properties of musculoskeletal tissues including tendon, can 
assist in understanding the aetiologies of injury (Ker et al. 1988; Seynnes et al. 2009) as well 
as physical performance potential (Fletcher et al. 2010; Lichtwark and Barclay 2010; Wilson 
et al. 1994). The primary parameter describing tendon material and mechanical properties is 
tendon stiffness, which describes the change in length in relation to the force applied (force-
displacement relation). It is dependent on the volume of the tendon and tendon modulus, 
which describes the relation between tendon stress and strain (McGinnis 2005). Therefore, 
the mechanical properties of tendon are influenced by the volume of tendon as well as the 
tissue material properties.
Recently, a genetic component has been associated with tendinopathies, particularly that of 
the COL5A1 rs12722 gene variant (Collins and Posthumus 2011). One previous study was 
able to associate this gene variant with mechanical properties of the muscle fascicles and 
aponeurosis of the vastus lateralis muscle (Kubo et al. 2013), although another was not when 
examining the patellar tendon (Foster et al. 2014). Therefore, we do not know that the 
behaviour of the two structures is necessarily comparable. In addition, gene variants within 
the MMP3 gene which encodes for matrix metalloproteinase-3 protein, a key regulatory 
enzyme of the extracellular matrix (ECM) capable of degrading multiple structural 
components of the ECM such as the collagens (Matrisian 1990), have also been associated 
with tendinopathies (Raleigh et al. 2009). Specifically, three gene variants within the MMP3 
gene (rs679620, rs591058, rs650108; see Figure 1) have independently been associated with 
chronic Achilles tendinopathies. Furthermore, the rs679620 gene variant is non-synonymous 
in that it causes a change in the amino acid sequence, and consequently an altered protein 
function.
Even though the above gene variants have not been associated with tendon dimensional and 
mechanical properties per se, it is however important to state that all genes that contain 
sequence variants shown to be associated with tendon injury to date, encode for proteins that 
serve essential structural and functional roles within tendon (Collins and Raleigh 2009). 
Indeed, down-regulated expression levels of MMP3 mRNA and its associated proteins have 
been found in injured or ruptured tendons compared to non-injured tendon groups (de Mos et 
al. 2007; Ireland et al. 2001; Jones et al. 2006; Lo et al. 2004; Riley et al. 2002). Therefore, it 
could be postulated that relatively small changes in MMP3 expression within non-
pathological ranges, as a result of the function of these gene variants, could result in 
interindividual variation in the degree of fibrillar collagen degradation, and ultimately the 
mechanical properties of tendon.
The aim of this study was therefore to investigate whether the MMP3 rs679620, rs591058 
and rs650108 gene variants influence dimensional and mechanical properties within the 
patellar tendon, through volume and modulus measures in vivo, in an asymptomatic 
population.
Method
Participants: From an initial screening phase, 160 healthy and recreationally active 
Caucasian individuals were recruited (100 males and 60 females). In an effort to increase the 
ability to detect genotype-phenotype associations, a  ‘stress the genotype’ approach was 
implemented (Montgomery et al. 2002).  Eighty-four participants (45 males and 39 females) 
with a high proportion of homozygosity across the three MMP3 gene variants completed the 
tendon phenotype assessments. ((mean, (range), (SD) age 23 (18-39), (4) years, height 173 
(153-191), (10) cm, body mass 71.6 (47.4-98.9), (12.4) kg, and BMI 24 (18.75-29.8), (2.8) 
kg/m2)). This ‘stress the genotype’ approach should increase the ability to detect a 
polymorphic influence on patellar tendon properties.
To minimise confounding factors, potential participants were not recruited if they; were non-
Caucasian; were very sedentary or very active (completed less than 2.5 hr/wk or more than 5 
hr/wk of moderate exercise (Tucker et al. 2011) as determined by a questionnaire); had any 
current or recent lower limb injuries in the past year before testing, including tendinopathies 
of the patellar tendon; were aged under 18 or over 40 years; were diabetic; smoked regularly; 
were regular users of medication; or had a body mass index (BMI) outside the range 18.5-30 
kg/m2. Female volunteers were not recruited if pregnant or using hormone-based 
contraception. The investigation was approved by the local ethics committee at Manchester 
Metropolitan University, and all participants gave their written informed consent to 
participate. The study conformed to the latest revision of the Declaration of Helsinki.
Measurement of tendon dimensional and mechanical properties
Maximal patellar tendon isometric force
All measurements of torque were carried out on an isokinetic dynamometer (Cybex, Phoenix 
Healthcare, UK) on the left leg. This instrument has been previously assessed for test-retest 
reliability for measures of peak torque of the knee extensors (Maffiuletti et al. 2007; 
McCleary and Andersen 1992). The knee was fixed at 90º flexion (full extension = 0º) and 
hip angle at 85º (supine position = 0º) and in order to minimise any extraneous movement of 
the hip joint or the trunk, participants were strapped over the shoulders, pelvis and thighs. 
Settings of chair height and positioning relative to the dynamometer were adjusted 
individually. Gravity corrections were then made following the manufacturers’ own 
procedure, having adjusted the attachment of the lever arm cuff relative to the length of the 
participant’s shank. Previous work from within our laboratory has utilised similar methods of 
measurement, finding them to be both valid and reliable (Onambele-Pearson et al. 2010; 
Onambele et al. 2007). Participants were instructed to perform ramp isometric knee 
extensions to maximum over a 5-7 s period. Maximal tendon force was calculated as 
described previously (Equation 1), (Onambele-Pearson and Pearson 2007; Pearson and 
Onambele 2006)
Equation 1: FMax = (MVC KE + CcT) / PTMA
where FMax is the maximal patella tendon force, MVC KE the maximal isometric knee-extensor 
torque (i.e. the measured torque during testing), CcT the knee flexion torque of the 
hamstrings during knee extension (antagonist co-contraction torque - see next section for 
calculation), and PTMA the patellar tendon moment arm (see sections below). 
Estimation of antagonist co-contraction using electromyography
Electromyographic (EMG) activity was assessed using a pair of self-adhesive Ag-AgCl 
electrodes (Ambu Neuroline 72000-S/25, Ballerup, Denmark) placed in a bi-polar 
configuration (Zipp 1982) at a site corresponding to the distal one-third on the long head of 
the biceps femoris (BF) (representative muscle of the knee flexors).The raw EMG signal was 
collected at a frequency of 2000 Hz, pre-amplified (× 2000), band pass filtered between 500 
and 10 Hz by the same system that processed the torque data (Acknowledge, Biopac Systems, 
Santa Barbara, CA, USA), and displayed in real-time on the same output graph (iMac, Apple, 
California). The root mean square (RMS) EMG activity corresponding to the peak torque 
period was analysed and averaged for a 500 ms period during the plateau of peak torque (i.e. 
250 ms either side of the instantaneous peak torque). These EMG data were used as a 
measure of antagonist co-contraction (i.e. CcT) during isometric knee extensions (Reeves et 
al. 2003), calculated as the product of BF EMG activity during MVCKE, divided by BF peak 
flexor EMG at 90º knee flexion MVC, multiplied by hamstrings maximal flexion torque.
Patellar tendon displacement
Patellar tendon displacement was determined using real-time B-mode ultrasonography (AU5, 
Esaote, Biomedica, Italy) as described previously (Onambele et al. 2007). Briefly, during a 
ramp isometric knee extension performed over 5-7 s with the knee fixed at 90º flexion, the 
ultrasound probe (7.5 MHz linear array probe, 40 mm wide) was positioned in a sagittal plane 
over the patellar tendon alternatively over; a) patella proximal (inferior pole of the patella) or 
b)  tibia-distal  (tibial  tuberosity)  excursions,  so  that  the  sum  of  tibial  and  patellar 
displacements would be computed as total displacement. Total displacements was determined 
at 10% PT force level intervals (from 10-100%) using digitising software (Kinovea, version 
0.8.15,  Joan  Charmant  &  Contributors,  France),  consistent  with  others  (Onambele  et  al. 
2007). This method is widely used and has high reliability (e.g. (Kubo et al. 2001; Pearson 
and  Onambele  2006;  Reeves  et  al.  2003)).  Measurements  were  taken  after  five 
preconditioning knee extension contractions to ensure reproducibility (Maganaris 2003), and 
in the early afternoon (between 1200h and 1500h), to minimise variability in tendon stiffness 
related to time of day (Pearson and Onambele 2006). 
Patellar tendon moment arm length   
Patellar tendon moment arm length (PTMA) was measured from an 11 s sagittal plane scan of 
the left leg of each participant at rest, using a single, low-energy X-ray beam (0.9 μSv) 
protocol on a DEXA (Dual X-ray Absorptiometry) scan (Hologic QDR, Vertec, Reading, 
UK). For the imaging limb, the participant lay on their right-hand side with the left hip and 
knee flexed at 90º so that the source detector probes could pass across the knee within a 20 
cm scanning window. The PTMA was defined as the perpendicular distance from the patellar 
tendon to the midpoint of the distance between the estimated tibio-femoral contact points in 
the lateral and medial femoral condyles (Baltzopoulos 1995; Tsaopoulos et al. 2006). The 
measurement of 2D PTMA using DEXA shows very strong agreement with MRI.
(Erskine et al. 2014).
Calculation of patellar tendon stiffness
Patellar tendon stiffness (K, N·mm-1), was calculated from the slope of the tangents of the 
force-displacement relations (at 10% force intervals), which were fitted with a second-order 
polynomial function forced through zero. The 10% force intervals derive from the average 
maximum force (FMax) experienced by the tendon during three separate ramp KE MVC (see 
Equation 1). The displacement of the patella tendon was measured as described previously. In 
addition, to allow for stiffness comparisons at an absolute load across populations, tendon 
stiffness was also calculated at a standardised force level which corresponded to just under 
the maximum baseline value of the weakest person (male=1067 N; female=1034 N)
Calculation of Elastic Modulus
Patellar tendon cross-sectional area (PTCSA) and patellar tendon length (PTL) were 
measured in the resting state at a knee joint angle of 90º. PTCSA was determined from the 
mean of transverse-plane ultrasound images taken at 25, 50 and 75% of patellar tendon 
length, and processed using digitising software (Image J, National Institute of Health, 
Bethesda, MD, USA). PTL was assessed from sagittal-plane ultrasound images and measured 
from the inferior pole of the patella to the superior aspect of the tibial tuberosity. Elastic 
Modulus (E) in GPa was calculated by multiplying K by the ratio of PTL to PTCSA (E = K × 
(PTL ÷ PTCSA).
Calculation of tendon volume
Patellar tendon volume (PTV) was calculated by geometric principles assuming a uniformly 
tapering truncated cone between measurement positions (i.e. the product of PTCSA at the 
three sections of the tendon, 25, 50, 75%, and PTL). However, these sections represent the 
‘central’ volume so it is possible that the normalisation is over-estimating the stress in the 
tendon, since not all the tissue is taken into account in the central 50% portion. Muscle and 
tendon geometry have previously been modelled using similar methods (Fuller et al. 1999; 
Jones and Pearson 1969; Tothill and Stewart 2002).
Z-score analyses: To provide a stable measure of the overall association of genotype with 
patellar tendon properties, composites were formed with unit-weighted Z-scores of 
constituent tests (Ackerman and Cianciolo 2000), i.e. Elastic Modulus and tendon volume. 
Hence, the dimensional (volume) and functional (Elastic Modulus) properties of tendon could 
be scaled and analysed simultaneously. Thus, the raw test scores of E (GPa) and volume 
(mm3) were converted to Z-scores using Equation 2;
Equation 2: Z-score = (variable score - mean)/standard deviation
Z-scoreComposite = Z-scoreE + Z-scorePTV
Genetic analysis
Sample collection
Buccal cells were collected using mouth swabs (Whatman Sterile OmniSwab, GE Healthcare, 
USA). Samples were immediately stored at -20ºC until DNA extraction.
DNA extraction
Standard procedures for genomic DNA isolation from buccal swabs were carried out using 
the Qiagen QIAcube spin column protocol and buffers in the Qiagen DNA Blood Mini kit 
(Qiagen, West Sussex, UK).
DNA Quantification
The concentration and purity of the sample was calculated using a biophotometer (WPA 
UV1101, Biochrom, Cambridge, UK). Briefly, 12 µL of the DNA sample was pipetted into a 
glass cuvette, the absorbance readings of ultra-violet light at wavelengths of 260 nm and 280 
nm were performed and the 260/280 nm ratio was determined. Good quality DNA will have a 
ratio of 1.7-2.0 (Glasel 1995), and all samples fell within these ratios. Eluted DNA 
concentrations were in the region of 10-30 ng/µL.
MMP3 genotyping
MMP3 rs679620, rs591058 and rs650108 genotypes were determined using fluorescence-
based TaqMan real-time polymerase chain reaction (PCR). Predesigned primers and allele-
specific probes specific to the ‘G’ allele (VIC) and ‘A’ allele (FAM) of the MMP3 rs679620 
gene variant, ‘C’ allele (VIC) and ‘T’ allele (FAM) of the MMP3 rs591058 gene variant, and 
‘A’ allele (VIC) and ‘G’ (FAM) of the MMP3 rs650108 gene variant, were used (Applied 
Biosystems, Foster City, CA, USA). The assay volume within each well of a 96-well PCR 
plate (Bio-Rad Laboratories Ltd, Herts, UK) was 10 µL, which included 1 µL of purified 
DNA, 5 µL of 2 X TaqMan genotyping master mix (Applied Biosystems), 0.5 µL of 20X 
genotyping assay (Applied Biosystems) and 3.5 µL nuclease-free H2O (Qiagen). Each PCR 
run included positive controls for each genotype and negative controls (sterile distilled 
water). The PCR plate was sealed using MicroSeal ‘B’ Adhesive seals (Bio-Rad) and ran on a 
Chromo4 Real-Time PCR Detection System (Bio-Rad) for 10 min at 95°C. This was 
followed by 40 cycles of denaturing at 92°C for 15 s, primer annealing and extension at 60°C 
for 60 s, and plate read. Genotypes were determined by endpoint fluorescence of VIC and 
FAM signals using the Chromo4 PCR machine, and results were analysed using Opticon 
Monitor Software version 3.1.32 (Bio-Rad). All analyses were run in duplicate, there was 
100% agreement between duplicate wells and genotyping was completed in all samples. 
Hardy-Weinberg Equilibrium
Genotype data were tested for Hardy-Weinberg Equilibrium (HWE) using a freely available 
software package (Rodriguez et al. 2009). This test was conducted on the initial cohort before 
selecting individuals for the phenotype tests (based on a higher degree of homozygosity), in 
order to establish whether the genotype and allele frequencies were constant between the 
initial cohort and the general population. Indeed, the genotype data for this cohort was in 
HWE (P > 0.05 with 1df (one degree of freedom)).
Oestradiol measures
It has been reported that oestradiol levels are associated with tendon mechanical properties in  
vivo (Burgess et al. 2009). Therefore, following the measures of  patellar tendon properties, 
female participants reported to the biochemistry laboratory where whole blood (5 mL) was 
drawn from a superficial forearm vein into serum separator tubes containing anti-coagulant 
(EDTA) (Sarstedt Monovette-Red cap, Numbrecht, Germany). After storage on ice for ~30 
minutes, the blood was centrifuged at 2-5°C for 10 min at 4100 rpm, with the supernatant 
extracted (~2 mL) and stored at -20°C for later analysis. Serum 17ß-oestradiol (E2) was 
quantitatively determined using standard enzyme-linked immunosorbent assay (ELISA) 
procedures (Alpha Diagnostic International, San Antonio, USA; minimal detectable 
concentration of ~10 pg/mL, intra-assay precision of 9.9%, inter-assay precision of 10.1%). 
E2 concentration at day 1 of the menstrual cycle was extrapolated using data from women 
with similar characteristics to those in the current study (i.e. age range 20-36 years, no use of 
contraceptives) (Stricker et al. 2006). Extrapolated serum oestradiol in the 39 female 
participants was therefore 34.0 (30.0) pg/mL.
Statistical power to detect genotype-phenotype associations
Statistical power calculations were performed using G*Power 3.1.6 software (Franz Faul, 
Universitat Kiel, Germany) (Faul et al. 2007). With alpha set at 0.05 and beta at 0.80, using 
mean and standard deviation data of patellar tendon properties obtained in our lab, it was 
estimated that approximately 80 participants would be required to detect differences in the 
order of ~1-2% for tendon volume and ~10-15% for tendon modulus between two genotype 
groups. Two genotype groups were used in this calculation because the intention, a priori, 
was to ‘stress the genotype’ (see first paragraph of Method) by conducting detailed phenotype 
testing on individuals homozygous for the polymorphisms under study where possible, while 
combining any small number of heterozygotes with one homozygote group. This was largely 
successful for rs591058 and rs679620 (cf. top row of Table 1 in Results) but less successful 
for rs650108 (cf. top row of Table 2) where statistical power therefore did not reach the target 
value.
Statistical analyses
Reliability of patellar tendon CSA, length, maximal displacement, and maximal strain  were 
evaluated using ratio limits of agreement (Nevill and Atkinson 1997) to quantify the absolute 
reliability or ‘agreement’ between measurements on separate occasions. All data were 
analysed with SPSS version 19.0.0. One-way analysis of variance (ANOVA) was performed 
on all three genotype groups and the measures of PTV and Z-scores. In addition, independent 
t-tests were performed on volume and Z-scores when combining heterozygotes with the 
smallest homozygote group. The Kruskal-Wallis non-parametric equivalent statistical test 
was performed on E and its association with the three genotype groups, while the Mann-
Whitney U test was used to compare E between one homozygote group and the other 
combined genotype group. PTV differed between sexes and BMI was correlated with both 
PTV and Z-score, so sex and BMI were used as covariates accordingly. Age and oestradiol 
concentration showed no correlations with any phenotype so were not used as covariates. 
Alpha was set at 0.05. Unless otherwise stated, data are presented as mean (standard 
deviation).
Figure 1 A simplified representation of the MMP3 gene in the negative orientation on 
chromosome 11. Both exons (black rectangles) and introns (horizontal lines) are shown, with 
exons being indicated by numbers. Untranslated regions (solid white rectangles) are also 
shown. All three gene variants are separated by similar distances; rs679620 in exon 2 is 2282 
base pairs from rs5901058 in intron 4, whereas rs591058 is 2551 base pairs from rs650108 in 
intron 8. This figure is modified from Raleigh et al. (2009) with information on minor allele 
frequency and loci derived from Ensembl (http://www.ensembl.org/index.html)
Results
There were no significant differences in age, height, mass and BMI between the three 
genotype groups, nor between the combined genotype groups of the MMP3 rs591058/679620 
gene variants (Table 1) and MMP3 rs650108 gene variant (Table 2). The MMP3 rs591058 
and rs679620 gene variants produced identical results and are therefore presented 
simultaneously, because they were in perfect linkage disequilibrium (LD) (allele C of 
rs591058 corresponded to allele G of rs679620). 
Between-day repeated measurements of tendon CSA, length, maximal displacement, and 
maximal strain in a subgroup of participants were examined using ratio limits of agreement. 
Tendon volume showed no bias and excellent agreement (×/÷ 1.019) and E showed no bias 
and very good agreement (×/÷ 1.144).
As circulating oestradiol levels showed no significant correlation with patellar tendon 
properties (CSA, r = 0.155, P = 0.345; Tendon length, r = -0.243, P = 0.137; Maximal 
displacement, r = -0.258, P = 0.113; Maximal strain, r = -0.171, P = 0.298; Maximal 
stiffness, r = 0.148, P = 0.368; Standardised stiffness, r = 0.267, P = 0.100; Volume, r = 
0.010, P = 0.950; E, r = 0.146, P = 0.375; Z-scores, r = 0.055, P = 0.740), and having 
adjusted for non-genetic factors such as sex and BMI, male and female participants data were 
therefore pooled into a single population. There were no significant differences in patellar 
tendon CSA, length, maximal displacement, maximal strain, stiffness at a common force 
level (Online Resource 1), or indeed tendon volume (P = 0.845) and E (P = 0.226) or Z-
scores (P = 0.654) (Figure 2), between the three genotype groups of the MMP3 
rs591058/679620 gene variants. Nor, were there any significant differences when comparing 
the TT/AA genotype groups to the combined CT and CC/GA and GG genotype groups 
(Volume, P = 0.859; E, P = 0.125; Z-scores, P = 0.357). Both the CT and CC/GA and GG 
genotype groups were combined due to the small CC and GG groups of the rs590158 and 
rs679620 gene variants, respectively.
 In addition, there were no significant differences between the three genotype groups of the 
MMP3 rs650108 gene variant in patellar tendon CSA, length, maximal displacement, 
maximal strain, and stiffness (Online Resource 2), or for measures of volume (P = 0.984), E 
(P = 0.088) or Z-scores (P = 0.390) (Figure 3). Or indeed, when comparing the GG genotype 
group to the combined GA and AA genotype groups (Volume, P = 0.881; E, P = 0.112; Z-
scores, P = 0.483).  The GA and AA genotype groups were combined due to the small AA 
group size.
Table 1 Age, physical characteristics and genotype at MMP3 rs591058 and rs679620 loci. P-
values for the comparisons of three genotype groups, and two genotype groups (when 
heterozygotes were pooled with one homozygote) were derived from a one-way ANOVA, 
and independent t-test, respectively. 
All
CC
GG
CT
GA
TT
AA
P-value 
(3 group 
comparison)
 CC & 
CT
GG & 
GA
P-value
 (2 group 
comparison)
n 84 29 6 49 - 35 -
Age (yr) 22.7 (4.0) 21.5 (2.3) 21.7 (0.8)
23.5 
(4.8) 0.247
21.5 
(2.2) 0.120
Sex (% male) 53.6 41.4 0 67.4 - 34.3 -
Height (cm) 172.7 (9.5) 171.9 (10.4) 167.8 (6.2)
173.7 
(9.2) 0.196
171.2 
(9.9) 0.179
Mass (kg) 71.6 (12.4) 70.5 (12.9) 62.7 (9.4)
73.3 
(12.0) 0.114
69.2 
(12.6) 0.129
BMI (kg.m-2) 24.0 (2.8) 24.1 (3.1) 24.7 (3.3)
23.8 
(2.5) 0.690
24.2 
(3.1) 0.477
Table 2 Age, physical characteristics and genotype at the MMP3 rs650108 loci. The P-values 
of the GG vs GA vs AA, and GG vs GA/GG combined genotype groups are derived from a 
one-way ANOVA, and independent t-test, respectively.
All GG GA AA
P-value 
(3 group 
comparison)
GA & AA
P-value 
(2 group 
comparison
n 84 61 15 8 - 23 -
Age (yr) 22.7 (4.0) 23.0 (4.5) 21.1 (2.3) 23.0 (2.5) 0.143 21.7 (2.5) 0.404
Sex (% 
male) 53.6 62.3 23.1 50 - 34.3 -
Height (cm) 172.7 (9.5)
173.5 
(9.4)
169.4 
(10.1)
172.7 
(8.7) 0.340
170.6 
(9.6) 0.216
Mass (kg) 71.6 (12.4)
72.9 
(12.5) 66.8 (12.2)
70.6 
(10.4) 0.218
68.1 
(11.5) 0.111
BMI (kg.m-
2) 24.0 (2.8) 24.1 (2.6) 23.2 (2.8) 24.7 (3.8) 0.408 23.7 (3.2) 0.628
Discussion
This study finds no association between the three variants of the MMP3 gene investigated, 
and patellar tendon properties. Specifically, the MMP3 gene variants investigated do not 
associate with dimensional (volume) and functional (E) properties of the patellar tendon, or 
indeed as a composite (Z-scores), in an asymptomatic population. In this study, patellar 
tendon modulus was comparable with other data for this phenotype in healthy, young, male 
and female combined subpopulations,  between 0.44-0.72 GPa compared with 0.5-0.6 GPa 
(O'Brien et al. 2010) and 0.75 GPa (Hsin-Yi and Paul 2010). The larger sample size used in 
the present study (n = 84) compared to those aforementioned studies (n = 10-20) (Hsin-Yi 
and Paul 2010; O'Brien et al. 2010) gives us increasing confidence that the modulus data are 
representative of the wider population. No previous study has reported PTV.
Although none of the variants investigated in this study were found to be associated with 
patellar tendon properties, it does not exclude the possibility that other variants within genes 
clustered in close proximity to the MMP3 gene on chromosome 11q22, such as MMP10, 
MMP1, and MMP12, are associated with patellar tendon properties. Like MMP3, the protein 
products of these genes are capable of degrading a diverse array of extracellular matrix 
(ECM) proteins (Pasternak and Aspenberg 2009; Somerville et al. 2003), so one might 
assume that because MMP3 variants have been associated with tendinopathies (Raleigh et al. 
2009), associations may be observed between these other MMP gene variants and tendon 
properties because the intrinsic regulatory proteins associated with tendon pathologies are 
also directly involved in non-pathological maintenance processes within tendon. 
Consistency of results when considering each of the three gene variants and measures of 
patellar tendon properties was expected, given that they are known to be in high linkage 
disequilibrium with one another. In particular, the rs591058 and rs679620 variants are in 
perfect linkage disequilibrium, with the ‘C’allele of rs591058 corresponding with the ‘G’ 
allele of rs679620. In addition, the rs650108 variant displays high linkage disequilibrium 
with the rs679620 and rs591058 variants (r = 0.673, P = 0.01).
A promoter polymorphism within the MMP3 gene (rs3025058) is also believed to be tightly 
linked to the rs679620 variant (Beyzade et al. 2003; Chen et al. 2012; Raleigh et al. 2009). 
Both markers are associated with MMP3 expression levels, notably the rs3025058 5A allele 
and the rs679620 ‘A’ allele are associated with relatively lower levels of MMP3, and the 
highest level of pathological activity related to rheumatoid arthritis. In addition, lower MMP3 
protein expression levels have been reported in human tendon displaying pathological 
characteristics (de Mos et al. 2007; Ireland et al. 2001; Jones et al. 2006; Parkinson et al. 
2010; Riley et al. 2002). These observations may represent a failure of the normal matrix 
remodelling process (Riley et al. 2002). However within a non-pathological range, lower 
MMP3 levels may favour a state of imbalance with greater synthesis relative to degradation, 
thus, substrates involved in cross-linking and stabilisation of intact fibrillar collagen may be 
relatively less affected by degradation processes. 
Ultimately, the AA genotype of the rs679620 variant may associate with a higher matrix 
stiffness and higher E, when considering the above rationale, yet this assumption was not 
evident in this study as E was not significantly different between the AA and GG genotype 
groups  (P = 0.226; 0.44 GPa vs. 0.48 GPa, respectively). Nor, was it evident in the only 
other previous genetic association study attempting to link this gene variant with tendon 
mechanical stiffness of the knee extensors and plantar flexors (Kubo et al. 2013). 
Correspondingly, the TT and CC genotype groups of the rs591058 variant do not differ 
significantly. However, the functional significance of the rs650108 variant has yet to be 
determined, most likely due to the fact that it resides in an intron, which makes it more 
difficult to explain why as part of a haplotype, it associates with pathological states (Koch et 
al. 2010; Raleigh et al. 2009). It may be that within normal physiological ranges, the activity 
of MMP3 is tightly controlled by tissue inhibitors of MMPs (TIMPs) (Riley 2005), thus 
inhibiting the degeneration of the ECM and loss of material properties. This has been 
reported in stress-deprived tendons in vitro, subjected to inhibitors to prevent the activation of 
MMP activity (Arnoczky et al. 2007). Therefore, variations in MMP3 activity related to 
differences in the ability to turn over the matrix may only become apparent following damage 
and the onset of pathological states.
We believe a valuable approach undertaken in this study was to increase the ability to detect 
genotype-phenotype associations. By recruiting a high proportion of participants from an 
original cohort who were homozygous for the gene variants under investigation, we were able 
to target our efforts during a detailed phenotype assessment. Hence, the genotype was being 
‘stressed’(Montgomery et al. 2002). Despite this approach, we observed no associations, 
although it is precisely because of our approach that we have confidence in our conclusions. 
Future researchers investigating gene variants and their association with tendon properties are 
encouraged to adopt this approach in synergy with a larger sample size where possible (a 
limitation of this study), to further increase the ability to detect associations of small effect 
size and provide even greater confidence in findings. Arguably, using a large sample size 
becomes even more important when considering that whole tendon mechanical properties are 
likely to be a product of the structure and function, and thus mechanical properties, of the 
ECM at a sub-structural level, i.e. the inter-fascicular matrix. Furthermore, a recent study’s 
findings in vivo (Pearson et al. 2014) suggests that there may be regional strain differences 
between the deep, middle, and surface structures at the proximal and distal aspects of the 
patellar tendon, exacerbating the difficulties of associating gene variants with whole tendon 
properties.
Future research should also attempt to determine whether there is a differential expression of 
MMP3 genes in tendon displaying relatively high and low tendon modulus, to assist in 
determining whether these genes are causally implicated in modifying mechanical properties 
of tendon, through mechanisms which remodel its microstructure. Additionally, associations 
could be established between protein expression levels and the genotypes of MMP3 sequence 
variants.
In conclusion, this study finds no evidence of an association between the three variants of the 
MMP3 gene investigated and dimensional and mechanical properties of the patellar tendon. 
However, our observations need replication and/or new study using other tendons. In 
addition, the relationship between pathological tendon conditions and tendon mechanical 
properties should be investigated to improve injury prevention models.
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